What Comes First In FDA Land, Excessive Claims Finding Or Facility Inspection?

Recent warning letters to Reviva Labs and Ageless Derma manufacturer Crescent Health Center cite claims violations brought to FDA's attention through inspections of the companies' manufacturing facilities. It's possible, however, that conspicuous website claims that overstep cosmetic boundaries are prompting inspections – further reason for companies to keep their claims in check.

More from Archive

More from HBW Insight